A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
Clinical trial NCT06025578 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06025578
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-25
- Primary completion
- 2027-12-27
- Enrollment
- 1057
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.